Last reviewed · How we verify
EMB-09
At a glance
| Generic name | EMB-09 |
|---|---|
| Sponsor | Shanghai EpimAb Biotherapeutics Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- EMB-09 CI brief — competitive landscape report
- EMB-09 updates RSS · CI watch RSS
- Shanghai EpimAb Biotherapeutics Co., Ltd. portfolio CI